WFM
IONS icon

Wilmington Funds Management’s Ionis Pharmaceuticals IONS Stock Holding History

Wilmington Funds Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$408K Sell
11,842
-3,131
-21% -$98.6K 0.04% 419
2014
Q1 		$647K Sell
14,973
-1,429
-9% -$69.3K 0.07% 281
2013
Q4 		$653K Buy
+16,402
New +$584K 0.07% 326

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wilmington Funds Management's IONS Position: Q2 2014 in Review

Wilmington Funds Management reduced its Ionis Pharmaceuticals (IONS) stake by 21% in Q2 2014, selling an estimated $98.6K and leaving 11,842 shares worth $408K. The position accounts for 0.04% of the portfolio, ranked #419.

Wilmington Funds Management first reported a position in IONS in Q4 2013 and has held it in 3 quarters since. The position peaked at $653K in Q4 2013. 238 funds tracked by Wall St. Rank hold IONS as of Q2 2014.

  • Wilmington Funds Management held 11,842 shares of Ionis Pharmaceuticals worth $408K as of Q2 2014.
  • Wilmington Funds Management sold 3,131 Ionis Pharmaceuticals shares in Q2 2014, an estimated $98.6K.
  • Ionis Pharmaceuticals made up 0.04% of Wilmington Funds Management's portfolio in Q2 2014, its #419 holding.
  • Wilmington Funds Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 3 quarters since.
  • Wilmington Funds Management's Ionis Pharmaceuticals position peaked at $653K in Q4 2013.
  • 238 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.